ThetaPal ThetaPal

Manufacturing / Medicinal Chemicals

Cronos Group Inc.

CRON

$3.22

+$0.01 (+0.31%)

Price as of Oct 10, 2026 01:22 UTC

1.3 B

Market Cap (Small Cap)

0%

IV Rank

41.0%

Implied Volatility

Nov 05

Next Earnings

Technical Signals as of Oct 7
Mixed
3 of 7

Trend

  • Above 20-day average $3.29
  • Above 50-day average $3.20
  • Above 200-day average $2.88 · +12.6%
  • Moving averages stacked 20 > 50 > 200

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) 116d ago

Volume

  • Below-average volume 0.5x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.01

Bullish skew

Implied Volatility

41.0%

0% percentile

IV vs Realized

Options cheap

30d HV 43.2%

Options Heat Map

Delta-risk grid for CRON options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 0 sells
Date Insider Title Type Shares Value Since Trade
Aug 06, 2026 Garnick Murray R Grant 48,860 $0 +4.9%
Aug 06, 2026 RUDYK JAMES DANIEL Grant 48,860 $0 +4.9%
Aug 06, 2026 ADLER JASON MARC Grant 48,860 $0 +4.9%
May 12, 2026 Doucet Terrence Gregory Joseph Exercise 10,597 $0 +16.2%
May 12, 2026 Kenost Jared Matthew Grant 30,000 $0 +16.2%
May 12, 2026 Buggy Shannon Other 9,179 $25,242 +17.1%
May 12, 2026 Doucet Terrence Gregory Joseph Exercise 10,597 $0 +16.2%
May 12, 2026 Kenost Jared Matthew Other 3,701 $10,178 +17.1%
May 12, 2026 Wagner Adam Exercise 10,367 $0 +16.2%
May 12, 2026 Doucet Terrence Gregory Joseph Other 5,199 $19,496 -14.1%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 05, 2026 Q2 2026 $0.00
Mar 31, 2026 Q1 2026 $0.00 $0.04 Beat
Dec 31, 2025 Q4 2025 $0.01 $0.00 -139.2% Miss
Sep 30, 2025 Q3 2025 $0.00 $0.08 Beat
Jun 30, 2025 Q2 2025 -$0.02 -$0.10 -390.2% Miss
Mar 31, 2025 Q1 2025 $0.00 $0.02 Beat

Track CRON with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for CRON and your entire portfolio.